***Background.*** Mupirocin ointment is often used to attempt eradication of colonization with methicillin-resistant *Staphylococcus aureus* (MRSA). However, mupirocin resistance, particularly among community-onset MRSA strains, has been increasing. This study sought to describe the prevalence and epidemiology of mupirocin resistance among community-dwelling subjects and their colonized household members.

***Methods.*** Over a three year time period, surveillance cultures for MRSA colonization were obtained from patients presenting to an ambulatory setting with an acute MRSA skin and soft tissue infection (i.e., index case) and their household members. All MRSA isolates obtained from subjects were evaluated for mupirocin minimum inhibitory concentration (MIC) using Etest®. Isolates with high-level mupirocin resistance (MIC \>512 µg/ml) were compared to susceptible isolates on the basis of SCCmec type, spa typing and susceptibilities to other commonly tested antimicrobials.

***Results.*** Four hundred thirty-four isolates were included in the analysis. Nineteen (4.4%) isolates demonstrated high-level mupirocin resistance (HLMR). Approximately half of these (47.4%) were isolated from index cases. The results are demonstrated in the table. Clindamycin resistance was seen more commonly among isolates with HLMR(42.1% vs 9.2%; P \< 0.001). No isolates demonstrated resistance to trimethoprim-sulfamethoxazole. No differences were seen by SCCmec type. The predominant *spa* type seen in both susceptible and HLMR isolates was t008. However, this was more commonly seen in susceptible isolates.

  Characteristic           Susceptible N=413   High-level Resistance N=19   P-value
  ------------------------ ------------------- ---------------------------- ---------
  Clindamycin resistance   38 (9.2)            8 (42.1)                     \<0.001
  SCCmec type              235 (56.7)          11 (57.9)                    0.91
   IV                      180 (43.3)          8 (42.1)                     0.90
   II                                                                       
  *spa* type               297 (71.9)          8 (42.1)                     0.005
   t008                    11 (2.7)            1 (5.3)                      0.50
   t002                    11 (2.7)            0 (0)                        0.47
   t024                    45 (10.9)           8 (42.1)                     \<0.001
   other                                                                    

***Conclusion.*** HLMR is associated with clindamycin resistance in MRSA surveillance culture isolates. Future studies should determine the rate of development of cross-resistance to other antimicrobials with mupirocin use.
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